Annual CAPEX
$919.00 K
+$546.00 K+146.38%
December 31, 2022
Summary
- As of February 10, 2025, JNCE annual capital expenditures is $919.00 thousand, with the most recent change of +$546.00 thousand (+146.38%) on December 31, 2022.
- During the last 3 years, JNCE annual CAPEX has fallen by -$66.00 thousand (-6.70%).
Performance
JNCE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
$223.00 K
-$17.00 K-7.08%
December 31, 2022
Summary
- As of February 10, 2025, JNCE quarterly capital expenditures is $223.00 thousand, with the most recent change of -$17.00 thousand (-7.08%) on December 31, 2022.
- Over the past year, JNCE quarterly CAPEX has increased by +$97.00 thousand (+76.98%).
Performance
JNCE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
$919.00 K
+$97.00 K+11.80%
December 31, 2022
Summary
- As of February 10, 2025, JNCE TTM capital expenditures is $919.00 thousand, with the most recent change of +$97.00 thousand (+11.80%) on December 31, 2022.
- Over the past year, JNCE TTM CAPEX has increased by +$546.00 thousand (+146.38%).
Performance
JNCE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
JNCE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +146.4% | +77.0% | +146.4% |
| 3 y3 years | -6.7% | +100.0% | -6.7% |
| 5 y5 years | -93.9% | -84.2% | -6.7% |
JNCE CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -59.4% | -36.1% | -52.0% | at high | -65.0% |
| 5 y | 5-year | -6.7% | -89.8% | -36.1% | -100.4% | -6.7% | -94.0% |
| alltime | all time | -93.9% | -89.8% | -96.8% | -100.4% | -93.9% | -94.0% |
Jounce Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $919.00 K(+146.4%) | $223.00 K(-7.1%) | $919.00 K(+11.8%) |
| Sep 2022 | - | $240.00 K(-31.2%) | $822.00 K(+22.3%) |
| Jun 2022 | - | $349.00 K(+226.2%) | $672.00 K(+108.7%) |
| Mar 2022 | - | $107.00 K(-15.1%) | $322.00 K(-13.7%) |
| Dec 2021 | $373.00 K(+296.8%) | $126.00 K(+40.0%) | $373.00 K(+30.4%) |
| Sep 2021 | - | $90.00 K(-9100.0%) | $286.00 K(+42.3%) |
| Jun 2021 | - | -$1000.00(-100.6%) | $201.00 K(-0.5%) |
| Mar 2021 | - | $158.00 K(+305.1%) | $202.00 K(+114.9%) |
| Dec 2020 | $94.00 K(-90.5%) | $39.00 K(+680.0%) | $94.00 K(+70.9%) |
| Sep 2020 | - | $5000.00(>+9900.0%) | $55.00 K(-88.4%) |
| Jun 2020 | - | $0.00(-100.0%) | $473.00 K(-48.9%) |
| Mar 2020 | - | $50.00 K(>+9900.0%) | $926.00 K(-6.0%) |
| Dec 2019 | $985.00 K | $0.00(-100.0%) | $985.00 K(-19.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $423.00 K(-6.6%) | $1.22 M(+26.7%) |
| Jun 2019 | - | $453.00 K(+315.6%) | $962.00 K(-22.3%) |
| Mar 2019 | - | $109.00 K(-53.4%) | $1.24 M(-8.9%) |
| Dec 2018 | $1.36 M(-91.0%) | $234.00 K(+41.0%) | $1.36 M(-46.5%) |
| Sep 2018 | - | $166.00 K(-77.2%) | $2.54 M(-38.1%) |
| Jun 2018 | - | $729.00 K(+217.0%) | $4.10 M(-50.3%) |
| Mar 2018 | - | $230.00 K(-83.7%) | $8.26 M(-45.3%) |
| Dec 2017 | $15.11 M(+579.9%) | $1.41 M(-18.3%) | $15.11 M(+3.0%) |
| Sep 2017 | - | $1.73 M(-64.6%) | $14.66 M(+8.2%) |
| Jun 2017 | - | $4.88 M(-31.0%) | $13.55 M(+56.4%) |
| Mar 2017 | - | $7.08 M(+631.1%) | $8.66 M(+445.7%) |
| Dec 2016 | $2.22 M | $968.00 K(+56.1%) | $1.59 M(+156.1%) |
| Sep 2016 | - | $620.00 K | $620.00 K |
FAQ
- What is Jounce Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Jounce Therapeutics?
- What is Jounce Therapeutics annual CAPEX year-on-year change?
- What is Jounce Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Jounce Therapeutics?
- What is Jounce Therapeutics quarterly CAPEX year-on-year change?
- What is Jounce Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Jounce Therapeutics?
- What is Jounce Therapeutics TTM CAPEX year-on-year change?
What is Jounce Therapeutics annual capital expenditures?
The current annual CAPEX of JNCE is $919.00 K
What is the all time high annual CAPEX for Jounce Therapeutics?
Jounce Therapeutics all-time high annual capital expenditures is $15.11 M
What is Jounce Therapeutics annual CAPEX year-on-year change?
Over the past year, JNCE annual capital expenditures has changed by +$546.00 K (+146.38%)
What is Jounce Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of JNCE is $223.00 K
What is the all time high quarterly CAPEX for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly capital expenditures is $7.08 M
What is Jounce Therapeutics quarterly CAPEX year-on-year change?
Over the past year, JNCE quarterly capital expenditures has changed by +$97.00 K (+76.98%)
What is Jounce Therapeutics TTM capital expenditures?
The current TTM CAPEX of JNCE is $919.00 K
What is the all time high TTM CAPEX for Jounce Therapeutics?
Jounce Therapeutics all-time high TTM capital expenditures is $15.11 M
What is Jounce Therapeutics TTM CAPEX year-on-year change?
Over the past year, JNCE TTM capital expenditures has changed by +$546.00 K (+146.38%)